elinzanetant Archives -

Bayer has added another clinical trial to its extensive phase 3 programme for oral neurokinin antagonist elinzanetant, hoping

Bayer extends elinzanetant trials to include breast cancer

https://pharmaphorum.com/news/bayer-extends-elinzanetant-trials-to-include-breast-cancer/

Astellas remains on course to be the first drugmaker to bring a new non-hormonal therapy for symptoms of

Astellas files menopause drug fezolinetant in US, setting up Feb verdict

https://pharmaphorum.com/news/astellas-files-menopause-drug-fezolinetant-in-us-setting-up-feb-verdict/

Astellas looks to be in pole position to bring a new non-hormonal therapy for symptoms of menopause to

Astellas’ eyes filings for menopause drug fezolinetant after ph3 win

https://pharmaphorum.com/news/astellas-eyes-filings-for-menopause-drug-fezolinetant-after-ph3-win/

elinzanetant